West Nile Virus (WNV) is a mosquito-borne flavivirus that causes significant morbidity and mortality in avian species worldwide. First isolated in Uganda in 1937, WNV emerged in North America in 1999, causing unprecedented bird mortality events.
Overview and Clinical Importance
West Nile Virus (WNV) is a mosquito-borne flavivirus that causes significant morbidity and mortality in avian species worldwide. First isolated in Uganda in 1937, WNV emerged in North America in 1999, causing unprecedented bird mortality events. Birds serve as the primary reservoir and amplifying hosts for WNV, making this disease critically important for avian medicine and public health. The virus has been detected in over 300 species of birds, with corvids (crows, jays, ravens) and raptors showing the highest susceptibility to fatal disease.
WNV is maintained in nature through a mosquito-bird-mosquito transmission cycle, primarily involving Culex species mosquitoes. Understanding WNV pathogenesis, clinical presentation, and diagnostic approaches is essential for veterinarians working with both wild and captive avian populations.
| Property |
Description |
| Genome |
Single-stranded, positive-sense RNA (approximately 11 kb) |
| Virion Size |
45-50 nm diameter, spherical, enveloped |
| Key Proteins |
Envelope (E) protein - primary target for neutralizing antibodies; prM/M membrane proteins; NS proteins (NS1-NS5) |
| Lineages |
At least 9 genetic lineages; Lineage 1 and 2 are most pathogenic and widespread |
| Environmental Stability |
Inactivated by heat, UV light, and common disinfectants; can persist in mosquitoes through vertical transmission |
Etiology and Viral Characteristics
Viral Classification: West Nile Virus belongs to the family Flaviviridae, genus Orthoflavivirus. It is a member of the Japanese encephalitis virus (JEV) serocomplex, which also includes St. Louis encephalitis virus (SLEV) and Murray Valley encephalitis virus.
Viral Structure and Properties
| Vector Species |
Geographic Region |
Common Name |
| Culex pipiens |
Eastern United States, Europe |
Northern House Mosquito |
| Culex tarsalis |
Western United States |
Western Encephalitis Mosquito |
| Culex quinquefasciatus |
Southeastern United States |
Southern House Mosquito |
Transmission and Epidemiology
Primary Transmission Cycle
WNV is maintained in nature through an enzootic cycle between mosquito vectors and avian reservoir hosts. Culex species mosquitoes are the primary vectors globally, with species variation by geographic region.
Primary Mosquito Vectors by Region
High-YieldWNV transmission is SEASONAL in temperate climates, peaking from July through October when mosquito populations are highest. Remember: Summer/Fall + Neurologic Signs in Birds = Think WNV!
Alternative Transmission Routes in Birds
- Oral transmission: Raptors can acquire WNV by consuming infected prey or carrion; documented in hawks, owls, and eagles
- Direct contact: Bird-to-bird transmission via contaminated oral secretions and feces; particularly significant in corvids during communal roosting
- Fecal-oral: Infected birds shed virus in feces for up to 93 days post-infection (documented in American Crows)
| Avian Group |
Susceptibility |
Mortality Rate |
Key Species |
| Corvidae |
HIGHEST |
Up to 100% (experimental) |
American Crow, Blue Jay, Ravens, Magpies |
| Raptors |
HIGH |
Variable; 50-90% |
Great Horned Owl, Red-tailed Hawk, Bald Eagle |
| Psittacines |
MODERATE-HIGH |
Variable by species |
Rosellas, Lorikeets, Conures |
| Wild Galliformes |
MODERATE |
Variable |
Greater Sage-Grouse, Ruffed Grouse |
| Domestic Poultry |
LOW |
Rare clinical disease |
Chickens, Turkeys (dead-end hosts) |
| Passerines (other) |
VARIABLE |
Often subclinical |
House Sparrows, Robins (amplifying hosts) |
Species Susceptibility and Mortality Patterns
Susceptibility to WNV-associated disease varies dramatically among avian species. Understanding species-specific patterns is crucial for clinical assessment and prognosis.
Board Tip - CROW Mnemonic: C = Corvids most susceptible, R = Raptors highly affected, O = Often fatal (up to 100% in crows), W = WNV should be suspected when dead crows are found!
| System/Category |
Clinical Signs |
| Neurological (PRIMARY) |
Ataxia, head tilt, torticollis, tremors, hind limb paresis/paralysis, seizures, nystagmus, apparent blindness, disorientation, inability to fly |
| Non-specific/Systemic |
Lethargy, weakness, depression, anorexia, weight loss/emaciation, fluffed feathers, dehydration, recumbency |
| Ophthalmologic |
Visual impairment, blindness, abnormal pupillary responses (common in Bald Eagles, Cooper's Hawks, Great Horned Owls) |
| Behavioral |
Abnormal tameness (easily approached/handled), stupor, coma, disorientation |
| Psittacine-specific |
Often found on cage bottom, sudden death without warning, ruffled feathers; may present with rapid decline |
| Corvid-specific |
Often found dead without clinical signs; if observed: rapid progression (death within 4 days of infection); recent survivors documented (2022) |
Clinical Signs and Presentation
Clinical presentation varies by species and disease severity. Many highly susceptible species die peracutely without premonitory signs. When clinical signs develop, they typically appear 5-6 days post-infection and progress rapidly.
Clinical Signs by System
High-YieldThe CLASSIC presentation for WNV in birds is neurological signs (ataxia, tremors, head tilt) + summer/fall seasonality + susceptible species (corvid or raptor). Death may occur within 24-48 hours of CNS invasion.
| Organ/Finding |
Gross Lesions |
| Heart |
Irregular pale streaks, mottling, or uniformly pale myocardium; subepicardial petechiae and ecchymoses |
| Brain |
Calvarial (intraosseous) hemorrhage - characteristic finding; meningeal hemorrhage; congestion |
| Spleen/Liver |
Mild to moderate splenomegaly and hepatomegaly; may appear mottled or congested |
| Body Condition |
Emaciation/cachexia common in raptors; loss of subcutaneous and visceral fat; pectoral muscle atrophy |
Pathology and Lesion Distribution
Gross Pathology (Necropsy Findings)
Important: Gross lesions are often minimal or absent, especially in peracute cases. When present, findings are typically non-pathognomonic.
Histopathology
Histopathological findings are more consistent than gross lesions and essential for diagnosis. The triad of encephalitis, myocarditis, and endophthalmitis is highly suggestive of WNV infection in susceptible species.
NAVLE TipThe HALLMARK histopathological lesions of WNV in birds are: (1) Nonsuppurative (lymphoplasmacytic) MENINGOENCEPHALITIS and (2) Necrotizing MYOCARDITIS. These two findings together should prompt WNV testing!
| Tissue |
Histopathological Findings |
| Brain/CNS |
Lymphoplasmacytic and histiocytic meningoencephalitis; perivascular cuffing; gliosis; glial nodules; neuronal necrosis and neuronophagia; Purkinje cell targeting (except corvids) |
| Heart |
Lymphoplasmacytic and histiocytic myocarditis (nonsuppurative); myocardial fiber degeneration and necrosis; mineralization and fibrosis in chronic cases |
| Kidney |
Interstitial nephritis; tubular epithelial necrosis |
| Liver |
Lymphoplasmacytic and histiocytic hepatitis; focal necrosis |
| Spleen |
Splenitis; lymphoid depletion in some cases |
| Eye |
Endophthalmitis; retinal necrosis (particularly in raptors) |
| Other |
Pancreatitis, enteritis, adrenalitis, perivasculitis, arteritis; pancreatic and adrenal necrosis |
Diagnostic Approach
Antemortem Diagnosis
Postmortem Diagnosis
High-YieldFor postmortem WNV diagnosis, always submit HEART, KIDNEY, and SPLEEN (pooled) for RT-PCR. Brain alone may give false negatives, especially in acute infections. Heart had the highest positivity rate (96%) in one study!
Differential Diagnoses
- Other encephalitic viruses: Highly pathogenic avian influenza (HPAI), Eastern equine encephalitis (EEE), St. Louis encephalitis (SLEV)
- Newcastle disease: Viscerotropic velogenic NDV, Avian paramyxovirus-1
- Parasitic encephalitis: Sarcocystis, Toxoplasma, Baylisascaris (roundworm neural larva migrans)
- Bacterial: Listeria, Salmonella, Erysipelothrix
- Toxicoses: Lead poisoning, organophosphates, ionophores
- Trauma: Head trauma, spinal injury
| Test |
Sample |
Notes |
| RT-PCR (preferred) |
Blood (whole or serum), oropharyngeal swabs (especially corvids), cloacal swabs |
Most sensitive antemortem test; detects viral RNA during acute viremia (1-2 weeks post-infection) |
| Serology (IgM ELISA) |
Serum (acute and convalescent paired samples) |
4-fold rise in titer indicates recent infection; single positive only shows prior exposure; limited commercial availability |
| PRNT |
Serum |
Plaque Reduction Neutralization Test - gold standard for serology; differentiates from SLEV cross-reactivity |
Treatment and Management
Important: There is NO SPECIFIC ANTIVIRAL TREATMENT for WNV in birds. Treatment is supportive and prognosis is generally poor in birds with severe neurological disease.
NAVLE TipIn 2022, Cornell University documented the FIRST American Crows to survive WNV infection with supportive care! The birds shed virus in respiratory secretions for up to 93 days post-infection. This breakthrough shows that supportive treatment CAN be successful in some cases.
| Test |
Preferred Tissues |
Notes |
| RT-PCR |
Heart (96% positive), Kidney (100%), Spleen (83%), Brain (88%) |
Pool small pieces of multiple tissues to maximize detection; most commonly used diagnostic test |
| Virus Isolation |
Heart, kidney, spleen, brain |
Requires BSL-3 facility; Vero cell culture; confirms active infection |
| Immunohistochemistry (IHC) |
Formalin-fixed tissues - heart, brain, kidney, pancreas, spleen |
Detects viral antigen in tissue sections; correlates with histopathology; cross-reacts with SLEV |
| Histopathology |
Brain, heart, kidney, liver, spleen |
Supportive evidence; should be combined with IHC or PCR for confirmation |
Prevention and Control
Vaccination
Key Point: There are NO commercially licensed WNV vaccines for birds. Several vaccine types have been tested off-label in captive birds.
High-YieldVaccination is generally limited to HIGHLY VALUABLE captive birds (endangered species, zoo collections, breeding programs). Immune response varies significantly by species, and booster immunizations are typically required. Maternal antibody interference may affect vaccination of juvenile birds.
Mosquito Control and Prevention Strategies
- Eliminate standing water: Remove containers, old tires, clogged gutters - mosquito breeding sites
- Water treatment: Use BTI (Bacillus thuringiensis israelensis) larvicides in standing water that cannot be drained
- Housing modifications: Keep birds indoors during peak mosquito activity (dusk/dawn/early evening); use fine-mesh screens on aviaries
- Seasonal awareness: Peak transmission July-October in temperate climates; increase vigilance during this period
- Surveillance: Report dead crows/corvids to public health authorities; participate in local surveillance programs
| Treatment Component |
Details |
| Fluid Therapy |
Parenteral fluids (SC, IV, IO) to correct dehydration and electrolyte imbalances; Lactated Ringer's Solution or Normosol-R |
| Nutritional Support |
Assisted/tube feeding if anorectic; appropriate diet for species; monitor body weight |
| Anti-inflammatory |
NSAIDs (meloxicam 0.5-1 mg/kg PO/IM q24h) for inflammation; use with caution |
| B Vitamins |
Thiamine (B1) supplementation for neurological support |
| Prophylactic Medications |
Antifungals (prevent secondary infections); antiparasitic treatment as needed |
| Housing |
Padded enclosure (prevent self-injury during seizures); supplemental heat if hypothermic; quiet, low-stress environment |
| Seizure Control |
Midazolam or diazepam for active seizures; phenobarbital for maintenance if needed |
Zoonotic and Public Health Considerations
WNV is a ZOONOTIC disease. Although the primary risk to humans is through mosquito bites (not direct bird contact), veterinary professionals should take precautions.
- Use PPE (mask, goggles, gloves) during necropsy to prevent aerosol/conjunctival exposure
- Handle dead birds with gloves or inverted plastic bags
- No documented human infection from casual bird contact
- Properly cooked game birds pose no transmission risk
- Human disease: approximately 1/150 (0.67%) infected humans develop severe neurological disease
| Vaccine Type |
Examples (Equine) |
Notes for Avian Use |
| Killed/Inactivated |
West Nile-Innovator, EQUIP WNV (Zoetis) |
Variable efficacy in birds; requires multiple boosters; some adverse reactions in lorikeets/spoonbills |
| Recombinant Canarypox |
RECOMBITEK Equine rWNV (Merial/Boehringer Ingelheim) |
May provide better cellular immunity; limited efficacy data in raptors (falcons) |
| DNA Plasmid |
Experimental only |
Research use; encodes E protein ectodomain |